Brain research supported by the European Union

Similar documents
Gesundheit in Horizont 2020

Mental Health. Patrizia Tosetti, PhD Unit F2 Medical Research DG Research and Innovation

EU support to hepatitis research. Anna Lönnroth Sjödén Health Research DG Research - European Commission

Horizon Introduction. Alex Harris Medical Research Council

Future of diabetes research in the EU- the EC perspectives

New Horizons for Vaccine R&D&I in Europe

Cancer Research in the EU Framework Programmes for RTD

Counting down to zero

Pain and Palliative care in the European Commission s Framework Programmes. European Commission Research DG Dr. Elengo Manoussaki

1. The Working Party on Public Health discussed and agreed the draft Council conclusions as set out in the Annex.

Council of the European Union Brussels, 28 October 2015 (OR. en)

DEMENTIA: IMPLEMENTATION REPORT AND CURRENT DEVELOPMENTS EU HEALTH

The Innovative Medicines Initiative: an engine for therapeutic innovation

Moving towards 2020 priorities for Public Health for the years Health and Consumers

Alcohol and Drug Commissioning Framework for Northern Ireland Consultation Questionnaire.

Welcome Note by Dr. Helge Braun, Parliamentary State Secretary

Joint Programming Initiative on Neurodegenerative Diseases. Prof. Philippe Amouyel Chair, JPND Management Board

BRAIN MISSION Understand - fix - enhance

CYPRUS PRESIDENCY OF THE COUNCIL OF THE EU

What EU research policy can do for conditions such as chronic pain?

14414/15 AF/evt 1 DG G 3 C

Dr.sc. Branka Bernard National Contact Point Member of the Programme Committee

A progress report on the Joint Programming Initiative

Future of Diabetes Research in Europe JDRF Perspective

Health and well-being a perspective from WHO

Joint Programming in Neurodegenerative Disease Research (JPND)

Filling Research Gaps to meet the Malnutrition Challenge : building evidences

The European Framework Program for Research & Innovation: Horizon 2020: Health, demographic change & wellbeing

An overview of EU funding for Brain and Related Diseases. Aldo Tagliabue

Clusters in Sports Industry: EU Approach and Support

Horizon Tailored screening as a research challenge. Mireille Broeders 30 January 2014, Bologna

The EU strategy in Horizon2020 to fight poverty related diseases

The HIV Prevention England programme: what s next? Cary James May 2016

EU funding of animal health research

15050/15 JS/pm 1 DGB 3B

The new PH landscape Opportunities for collaboration

DEVELOPMENT. The European Union confronts HIV/AIDS, malaria and tuberculosis. A comprehensive strategy for the new millennium EUROPEAN COMMISSION

Exemplary Project. O.P.E.C.E. - LUXEMBOURG April 2018

Table Of Content. Page 1/8

European actions in the field of transplantation & blood transfusion

CHARTING THE COURSE FOR CANADA S NATIONAL DEMENTIA STRATEGY PRE-BUDGET SUBMISSION TO THE HOUSE OF COMMONS STANDING COMMITTEE ON FINANCE

The European Asthma Research & Innovation Partnership tackling Europe s high asthma prevalence and death rates

The European Brain Council

First European Parliament Conference on Complementary and Alternative Medicine, CAM.

Making dementia a European priority

ROLE SPECIFICATION FOR MACMILLAN GPs

Draft of the Rome Declaration on Nutrition

Submission to Standing Committee on Health. With no leadership, Canada s diabetes crisis will continue to get worse

Non communicable diseases

Priority Medicines for Europe and the World: Setting a public health based medicines development agenda

Worcestershire's Autism Strategy

THE VALUE OF TREATMENT FOR BRAIN DISORDERS A NEW VISION IN PROGRESS...

NORDIC CONFERENCE ON RARE DISEASES

Table Of Content. Page 1/8

COU CIL OF THE EUROPEA U IO. Brussels, 27 July /09 ADD 2 SA 202 SOC 459 RECH 237 COVER OTE

ARE Position Paper: Women and Sustainable Energy

Maltese Presidency of the Council of the European Union. Ministry for Health

The EU rare diseases policy framework: the context for ERNs

Healthy Lives & Healthy Food

Foreword. Our shared principles

FP7 PEOPLE PROGRAMME. MARIE CURIE Host - Driven ACTIONS Calls 2012

Action Plan on HIV/AIDS in the EU and neighbouring countries:

Symposium Gendered Innovations. March 28, Simone Buitendijk

Statement Of. The National Association of Chain Drug Stores. For. U.S. House of Representatives Committee on the Budget.

R&D Status in Romania

E-RARE & THE EUROPEAN JOINT PROGRAMME ON RARE DISEASES. RE(ACT) 2018 Congress 7-10 of March 2018 Bologna, ITALY

From IMI to IMI2. Hugh Laverty Senior Scientific Project Manager

An Active Inclusive Capital. A Strategic Plan of Action for Disability in London

Multi-sectoral aspects of pandemic preparedness and response

ADVANTAGE JA Joint Action on Prevention and Management of frailty Prof. Leocadio Rodríguez Mañas Coordinator ADVANTAGE

EUCERD Recommendations on Rare Disease European Reference Networks (RD ERNs)

PREVENTION FIRST : VACCINATION AT THE HEART OF PUBLIC HEALTH

Agenda 2030: One Nation Labour s Plan for science Response from Alzheimer s Research UK

Retina International General Assembly Auckland, New Zealand

14 December :00 CET

On the occasion of World Digestive Health Day 2013: The importance of research into liver cancer and alcohol as a risk factor

Moorfields Eye Charity Strategy People's sight matters

INVESTING IN A NEW FINANCING MODEL FOR THE SUSTAINABLE DEVELOPMENT ERA

Pfizer Support to European and International Patient Organisations based in Belgium & Luxembourg in 2016

Strengthening efforts to improve access to and affordability of medicines and technologies in the prevention and control of NCDs

Dementia in England. Dr Charles Alessi Senior Advisor on Dementia, Public Health England

SUPPORTING COMPANIES GO INTERNATIONAL FOR RESEARCH AND INNOVATION

Spreading Excellence and Widening Participation

Towards tailored and targeted asthma self-management using mobile technologies

ESRC-NIHR dementia research initiative 2018 outline call Call specification

HORIZON The European Union s support for cancer research: towards personalised medicine. The EU Framework Programme for Research and Innovation

Supplementary Table 1 - Grand priority candidates: Ranking based on percentage of votes received from GP-TCM members and external participants

Monitoring of the achievement of the health-related Millennium Development Goals

National Dementia Vision for Wales Dementia Supportive Communities

Improving Healthcare Together

PUBLIC POLICIES AND ALZHEIMER RESEARCH

NIH FY 2017 Budget Roll-Out Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health February 9, 2016

A pan European Dementia Strategy

Open Access to publications and research data in Horizon 2020

Annual General Meeting

Australasian Sleep Association

European Innovation Partnership on Active and Healthy Ageing

OPERATIONAL FRAMEWORK. for the Global Strategy for Women s, Children s and Adolescents Health

Project Manager Mental Health Job Description and Application Pack

Transcription:

Brain research supported by the European Union Lara Passante, PhD Health Directorate Directorate-General for Research & European Commission FENS Featured Regional Meeting 11-14 Septembre 2013 Prague

Neuroscience: Seventh Framework Programme Horizon 2020

Current EC health research activities Total FP7 budget: 54.6 billion Health Priority in Cooperation: 6.1 billion JRC (EC) Euratom 1.8 Capacities 4.1 4.3 People 4.7 7. 5 Ideas Cooperation 32.3

FP7 Health state of play 4 billion EUR currently invested in 844 on-going collaborative projects ~3000 organisations from 122 countries involved Leading role in 6 global research consortia 1 billion EUR investment in Europe's largest public-private initiative for better and safer medicines

What type of disease? 700 600 500 562 497 582 Euratom JRC Capacities People Cooperation 400 Ideas 300 254 255 200 100 134 149 126 0 2,5 Billion Euro

FP7 Brain Research Overall FP7 funding support for brain research Brain functions and processes 750.885.831 Neurodegenerative disorders Neurological disorders (excl. neurodegenerative 401.715.510 401.863.292 Neuropsychiatric disorders 283.878.877 Public Health Rare brain disorders 74.844.049 70.108.591 EUR 1.98 billion

Overall FP7 funding support for research on neurological disorders (excl. neurodegenerative) FP7 Brain Research Neurosurgical diseases 209.688.429 Other Neurological diseases 165.447.352 Neuroinflammatory diseases 67.286.708 Neurological infectious diseases 18.524.562 EUR 460 million

FP7 Brain Research Overall FP7 funding support for research on neurodegenerative diseases Alzheimer's disease 201.975.380 Parkinson's disease 167.580.779 Other neurodegenerative diseases 69.622.987 Motorneuron diseases 58.139.820 Retinal diseases 33.350.795 Lysosomal storage diseases 5.399.167 EUR 563 million

FP7 Brain Research Overall FP7 funding support for research on neuropsychiatric diseases Schizophrenia 102.017.237 Other psychiatric diseases 73.382.429 Autism 68.178.357 Depression + Bipolar disorders 57.353.776 EUR 300 million

Contribution to EU27 and Associated countries FP7 Brain Research

FP7 Brain Research FP7 Brain research : EU27 and Associated countries connections

Month of the Brain Month of the Brain: Draft Stakeholders Recommended policy principles and objectives-draft (1/3): 1. Promote the role of patients in all stages of research and evidence-based healthcare 2. Tackle the stigmatization of patients with brain disorders 3. Continue supporting interdisciplinary research approaches

Month of the Brain Draft Stakeholders Recommended policy principles and objectives (2/3): 4. Foster innovative and more relevant approaches to clinical development 5. Promote new ways of implementing healthcare solutions 6. Encourage data sharing 7. Attract and align public and private investment into brain research and healthcare 8. Expand smart and innovative strategies for supporting brain research and healthcare

Month of the Brain Draft Stakeholders Recommended policy principles and objectives (3/3): 9. Reward innovation in drug development, new technologies and healthcare delivery 10.Adapt the regulatory landscape Month of the Brain at: http://ec.europa.eu/research/conferences/2013/ brain-month/index_en.cfm

Horizon 2020 Horizon 2020: The next framework programme for research and innovation Europe needs cutting edge research and innovation Essential to ensure competitiveness, growth and jobs Vital to tackle pressing societal challenges 3% of GDP invested in R&D: headline target of Europe 2020

Horizon 2020 Three priorities: 1. Excellent science 2. Industrial leadership 3. Societal challenges

Horizon 2020 What s new A single programme bringing together three separate programmes/initiatives Coupling research to innovation from research to retail, all forms of innovation Focus on societal challenges facing EU society, e.g. health, clean energy and transport Simplified access, for all companies, universities, institutes in all EU countries and beyond.

Horizon 2020 Towards Horizon 2020: more money for health research in times of austerity? Investing into the right research pays off: Better, more personalised and costefficient treatments Fewer chronic patients will drive down healthcare costs Greater focus on innovation Growth and jobs

Horizon 2020 The Health Challenge: some of the key features Understanding health, wellbeing and disease Preventing disease Treating and managing Active ageing and selfmanagement of health Adapting to an ageing population Personalised medicine Translational research Clinical trials Private sector competitiveness, capability Coordination of national efforts Methods and data Health care provision and integrated care Reduce costs: CER Expanding global cooperation

Follow Horizon 2020 at: http://ec.europa.eu/research/horizon2020/index_e n.cfm Month of the Brain at: http://ec.europa.eu/research/conferences/2013/br ain-month/index_en.cfm Thank you for your attention